Have some news you want to share with the Oregon Bio community? Fill out our submission form.
2020 was a year like no other in biotech and the life sciences, and the need for a pivot-worthy workforce has never been more needed. While physicians and care providers serve diligently as responders in critical patient care delivery, behind them are myriad researchers and technologists who work to conquer the virus. In our industry, clinicians and researchers created, tested and applied safety and efficacy of vaccines and therapies. Data scientists studied epidemiology around the world and here in the […]
By Elizabeth Hayes – Staff Reporter, Portland Business Journal, 2/9/2021
Genentech’s $175 million expansion in Hillsboro is almost complete.
The biotech giant is getting ready to open a 130,000-square-foot expansion in Hillsboro, where it already has a major operation, by the end of the first quarter.
Based in south San Francisco, Genentech’s Technical Operations facility in Hillsboro has “played a key role in the filling, packaging and distribution of Genentech […]
FOR IMMEDIATE RELEASE – – February 8, 2021
With Snyder, Executive Committee members include Sandra Shotwell, Ph.D., co-founder at Elex Biotech, LLC; Tim Brown, site head and general manager at Genentech; Brenna Rauw, Managing Director at 12Bridge; and Michael Phillips, attorney at Davis Wright Tremaine LLP, as general counsel.
Winning researchers and startup entrepreneurs capture prizes in four categories at Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics conference
(Portland, Ore.) – Winners are now being announced for the Oregon Bioscience Association’s Pitch & Partner 2020 in recognition of local emerging research and successful life science and biotech startups. The pitches and real-time judging occurred at the annual conference’s digital event, Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics Conference, which took place in […]
Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics happens over three half-days Nov. 17, 18, 19 and brings together investors, start-up entrepreneurs, executives, researchers, policymakers and bio-supply chain sector executives #OregonBioDigital
How the Pacific Northwest accelerates and amplifies the growth and diversity of our life science and biotech clusters will be under the microscope at the Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics Conference, happening over three half-days November 17, 18 and 19.
Synthetic biology startup AbSci raises $65M to expand ‘Protein Printing’ tech
Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform.
The company’s “Protein Printing” technology is used to discover and manufacture complex biological molecules such as antibodies and insulin.
The AbSci platform is composed of two products: SoluPro, a synthetic biology platform based on genetically engineered E. […]
Emerging bio and lab in Portland IQ named in Top 5 Projects Under Construction by Commercial Property Executive
Top 5 Office Projects Under Construction in Portland
Based on Yardi Matrix data, 2.5 million square feet of office space was underway as of October, including the metro’s first biotech facilities and the largest urban asset in a decade.
Portland, Ore., has been diversifying its economy in the past few years, becoming better-positioned to face the coronavirus-generated fallout and uncertainty. According to Yardi Matrix data, the metro’s development pipeline included some 2.5 million square feet of office space […]
Thermo Fisher Scientific Inc. executives said the company expects 2020 revenue to grow 20% to about $30.52 billion, its first full-year outlook since it withdrew guidance in April due to Covid-19 uncertainty.
The scientific-equipment and diagnostics company also expects adjusted earnings to rise 48% to $18.27 a share for the year, executives said on a conference call Wednesday.
The estimates are higher than the outlook it put out in late January, when it guided for adjusted earnings […]
— Veklury Is First and Only FDA-Approved Treatment for COVID-19 in the United States —
— Veklury Shortened Time to Recovery By Five Days in Hospitalized COVID-19 Patients —
Gilead Sciences, Inc. (Nasdaq: GILD) announced on Oct. 22 that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury® (remdesivir) for the treatment of patients with COVID-19 requiring hospitalization. As an antiviral drug, Veklury works to stop replication of SARS-CoV-2, the virus that causes COVID-19. Previously authorized by the […]